Smoking and Cognition: The Risk, and What Happens When People Stop

Smoking appears in essentially every list of modifiable dementia risk factors, and unlike most items on such lists, the causal case is unusually strong — supported by mechanism, dose-response, and consistency across populations.

The association

Current smokers have been found in multiple large studies to have higher rates of cognitive decline and dementia diagnosis than non-smokers, with risk generally increasing with amount and duration. Reviews of modifiable dementia risk factors have consistently included smoking.

The mechanisms are mostly not mysterious:

Vascular damage. Smoking accelerates atherosclerosis, raises stroke risk and damages small vessels, including those supplying the brain.
Oxidative stress and inflammation, both elevated in smokers.
Reduced oxygen delivery, through carbon monoxide binding and impaired lung function.
Increased risk of conditions that themselves carry cognitive risk, including cardiovascular disease and diabetes.

The nicotine confusion

Nicotine has short-term effects on attention and has been studied for cognitive properties, which has sometimes been misread as evidence that smoking benefits cognition.

Two things resolve the confusion. First, much of the apparent boost in regular smokers is relief from withdrawal rather than enhancement above baseline — the same pattern seen with caffeine. Second, whatever nicotine does in isolation is delivered in tobacco smoke alongside thousands of other compounds with well-documented vascular and carcinogenic effects.

On e-cigarettes

The long-term cognitive effects of e-cigarette use are not established, largely because the products have not existed long enough for the relevant research. Absence of evidence here is genuinely absence of evidence rather than evidence of safety. Public health positions differ across countries on their role in smoking cessation, and this is a question for a clinician rather than a website.

What happens after quitting

This is the part worth emphasising. Observational research has generally found that former smokers show risk profiles closer to never-smokers than to current smokers, with the difference appearing to grow with time since quitting.

The cardiovascular benefits of cessation are well established and begin relatively quickly. Since a substantial part of the cognitive risk appears to run through vascular routes, this is the most likely explanation for the pattern.

The practical message is that quitting at any age is associated with benefit, and the common belief that damage is already done and cessation is pointless is not supported.

Getting support

Cessation succeeds far more often with support than through willpower alone. Approaches with established evidence include behavioural support, nicotine replacement therapy, and prescription medications. Combining behavioural support with pharmacotherapy generally performs better than either alone.

Most health systems provide cessation services, often free. A doctor or pharmacist can advise on what is appropriate, including for people with other medical conditions.

Second-hand smoke

Some research has examined associations between second-hand smoke exposure and cognitive outcomes, with findings suggesting exposure may carry risk. The evidence base is smaller than for active smoking, but it is one more reason for smoke-free environments, particularly where children or older adults are present.

Where this sits

Among everything covered on this site, smoking cessation is near the top for evidence strength and for magnitude of effect on overall health, not only cognition. It is also considerably harder to do than taking a supplement, which may be part of why the supplement gets more attention.